Sign In
Buy ATHA
$6.61
+0 (+0%)
At Close: Apr 14, 2026
Biotech Losers In 2021 That Could Bounce Big In The Second Half
05:02pm, Saturday, 03'rd Jul 2021
Biotech stocks are tricky investment bets that require careful analysis and scrutiny. A stock that has fallen off a cliff in reaction to a binary event can neither be written off entirely nor picked a
Philadelphia, Pennsylvania--(Newsfile Corp. - July 3, 2021) - Berger Montague is investigating potential securities fraud claims against Athira Pharma, Inc. ("Athira" or the "Company"). The Firm is in
Athira Update
08:50pm, Friday, 02'nd Jul 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Athira To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor
Philadelphia, Pennsylvania--(Newsfile Corp. - July 2, 2021) - Berger Montague is investigating securities fraud allegations against Athira Pharma, Inc. ("Athira" or the "Company"). The Firm is investi
NEW YORK--(BUSINESS WIRE)-- #ATHA--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of class action lawsuits on behalf of purchasers of the securities of Athira Pharma, Inc
Los Angeles, California--(Newsfile Corp. - July 2, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athira Pharma, Inc
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athira Pharma, Inc. - ATHA
10:35pm, Thursday, 01'st Jul 2021
NEW YORK, July 1, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of. Athira Pharma, Inc. ("Athira" or the "Company") (NASDAQ: ATHA).
Athira Class Action Reminder
08:48pm, Thursday, 01'st Jul 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Athira To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor
NEW YORK, July 1, 2021 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for t
SHAREHOLDER ALERT: Robbins LLP Announces that Athira Pharam, Inc. (ATHA) is Being Sued for Misleading Shareholders
02:43pm, Thursday, 01'st Jul 2021
SAN DIEGO & BOTHELL, Wash.--(BUSINESS WIRE)---- $ATHA #ATHA--Shareholder rights law firm Robbins LLP announces that several class actions have been filed on behalf of all purchasers of Athira Pharma,
Philadelphia, Pennsylvania--(Newsfile Corp. - July 1, 2021) - Berger Montague is investigating securities fraud allegations against Athira Pharma, Inc. ("Athira" or the "Company") on behalf of investo
Los Angeles, California--(Newsfile Corp. - July 1, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athira Pharma, I
Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Athira Pharma, Inc. - ATHA
05:25pm, Wednesday, 30'th Jun 2021
RADNOR, Pa., June 30, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that securities fraud class action lawsuits have been filed against Athira Pharma, Inc. (NASDAQ:
LOS ANGELES--(BUSINESS WIRE)---- $ATHA #ATHA--SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc.
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Athira Pharma, Inc. (ATHA) Investors
12:20pm, Wednesday, 30'th Jun 2021
LOS ANGELES--(BUSINESS WIRE)---- $ATHA #investors--The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Athira Pharma, Inc. (ATHA) Investors
